JP2021505568A5 - - Google Patents

Download PDF

Info

Publication number
JP2021505568A5
JP2021505568A5 JP2020530502A JP2020530502A JP2021505568A5 JP 2021505568 A5 JP2021505568 A5 JP 2021505568A5 JP 2020530502 A JP2020530502 A JP 2020530502A JP 2020530502 A JP2020530502 A JP 2020530502A JP 2021505568 A5 JP2021505568 A5 JP 2021505568A5
Authority
JP
Japan
Prior art keywords
methyl
hydrogen
membered
optionally
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020530502A
Other languages
English (en)
Japanese (ja)
Other versions
JP7167155B2 (ja
JP2021505568A (ja
Filing date
Publication date
Priority claimed from GBGB1720189.8A external-priority patent/GB201720189D0/en
Priority claimed from GBGB1804439.6A external-priority patent/GB201804439D0/en
Application filed filed Critical
Priority claimed from PCT/PT2018/050043 external-priority patent/WO2019112457A1/en
Publication of JP2021505568A publication Critical patent/JP2021505568A/ja
Publication of JP2021505568A5 publication Critical patent/JP2021505568A5/ja
Application granted granted Critical
Publication of JP7167155B2 publication Critical patent/JP7167155B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020530502A 2017-12-04 2018-11-30 ドーパミン-β-ヒドロキシラーゼ阻害剤 Expired - Fee Related JP7167155B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB1720189.8 2017-12-04
GBGB1720189.8A GB201720189D0 (en) 2017-12-04 2017-12-04 Dopamine-B-hydroxylase inhibitors
GB1804439.6 2018-03-20
GBGB1804439.6A GB201804439D0 (en) 2018-03-20 2018-03-20 Dopamin-b-hydroxylase inhibitors
PCT/PT2018/050043 WO2019112457A1 (en) 2017-12-04 2018-11-30 Dopamine-β-hydroxylase inhibitors

Publications (3)

Publication Number Publication Date
JP2021505568A JP2021505568A (ja) 2021-02-18
JP2021505568A5 true JP2021505568A5 (cg-RX-API-DMAC10.html) 2022-01-11
JP7167155B2 JP7167155B2 (ja) 2022-11-08

Family

ID=65012066

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020530502A Expired - Fee Related JP7167155B2 (ja) 2017-12-04 2018-11-30 ドーパミン-β-ヒドロキシラーゼ阻害剤

Country Status (16)

Country Link
US (2) US11434242B2 (cg-RX-API-DMAC10.html)
EP (1) EP3720856A1 (cg-RX-API-DMAC10.html)
JP (1) JP7167155B2 (cg-RX-API-DMAC10.html)
KR (1) KR20200096584A (cg-RX-API-DMAC10.html)
CN (1) CN111479812A (cg-RX-API-DMAC10.html)
AU (1) AU2018379646A1 (cg-RX-API-DMAC10.html)
BR (1) BR112020010216A2 (cg-RX-API-DMAC10.html)
CA (1) CA3082337A1 (cg-RX-API-DMAC10.html)
CL (1) CL2020001461A1 (cg-RX-API-DMAC10.html)
IL (1) IL274550B2 (cg-RX-API-DMAC10.html)
MX (1) MX2020005864A (cg-RX-API-DMAC10.html)
PH (1) PH12020500542A1 (cg-RX-API-DMAC10.html)
RU (1) RU2020121820A (cg-RX-API-DMAC10.html)
SG (1) SG11202004231YA (cg-RX-API-DMAC10.html)
TW (1) TW201925193A (cg-RX-API-DMAC10.html)
WO (1) WO2019112457A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019112457A1 (en) 2017-12-04 2019-06-13 BIAL - PORTELA & Cª, S.A. Dopamine-β-hydroxylase inhibitors
GB201908044D0 (en) 2019-06-05 2019-07-17 Bial Portela & Ca Sa Dopamine-B-Hydroxylase inhibitors
TW202528310A (zh) * 2023-09-20 2025-07-16 美商深蘋果治療股份有限公司 經取代胺化合物,組合物及使用方法
WO2025161144A1 (zh) * 2024-01-29 2025-08-07 上海深势唯思科技有限责任公司 芳基杂环类Kv1.3抑制剂及其制备方法和用途

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3647790A (en) 1969-04-08 1972-03-07 American Home Prod Ouinoxalinyl-oxazolidines and -oxazines
FR2449689A1 (fr) 1979-02-20 1980-09-19 Logeais Labor Jacques Nouveaux derives condenses de pyrrolidine ou de piperidine, leur procede de preparation et leurs applications en therapeutique
US4628059A (en) 1985-10-31 1986-12-09 Smithklein Beckman Corporation Dopamine-β-hydroxylase inhibitors
ES2201104T3 (es) 1994-04-26 2004-03-16 Roche Palo Alto Llc Derivados de benzociclohexilimidazoltiona.
US6482982B1 (en) 2001-03-09 2002-11-19 University Of Sciences Of Philadelphia Halogenated antituberculosis agents
IL143379A (en) * 2001-05-24 2013-11-28 Yissum Res Dev Co Oligonucleotide against human ache isoform r and its uses
US7125904B2 (en) * 2002-10-11 2006-10-24 Portela & C.A., S.A. Peripherally-selective inhibitors of dopamine-β-hydroxylase and method of their preparation
WO2008085008A1 (en) * 2007-01-11 2008-07-17 Mogam Biotechnology Research Institute T-cell inhibiting compounds and their use for the treatment of t-cell-mediated diseases
GB0708818D0 (en) * 2007-05-08 2007-06-13 Portela & Ca Sa Compounds
NZ583193A (en) 2007-07-23 2012-05-25 Biotie Therapies Inc Treatment of post-traumatic stress disorder with nepicastat
US8110578B2 (en) * 2008-10-27 2012-02-07 Signal Pharmaceuticals, Llc Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway
US20150376198A1 (en) 2013-02-18 2015-12-31 The Scripps Research Institute Modulators of vasopressin receptors with therapeutic potential
JOP20190049A1 (ar) 2016-09-23 2019-03-20 Bial Portela & C? S A مثبطات دوبامين-b-هيدروكسيلاز
WO2019112457A1 (en) 2017-12-04 2019-06-13 BIAL - PORTELA & Cª, S.A. Dopamine-β-hydroxylase inhibitors

Similar Documents

Publication Publication Date Title
HRP20201641T1 (hr) Novi spojevi i njihove farmaceutske kompozicije za liječenje inflamatornih poremećaja
ES2629414T3 (es) Derivados de tiazol
JP2016523911A5 (cg-RX-API-DMAC10.html)
JP2023071767A (ja) Brm標的化化合物および関連使用方法
ES2901197T3 (es) Moduladores alostéricos de los receptores nicotínicos de la acetilcolina
JP5911638B2 (ja) ベンゾチアゾール−6−イル酢酸誘導体およびhiv感染を処置するためのそれらの使用
JP2009529047A5 (cg-RX-API-DMAC10.html)
RU2016102137A (ru) Первичные карбоксамиды в качестве ингибиторов bik
CA2831966C (en) Thiazole derivatives
RU2665036C2 (ru) Гетероароматические соединения-модуляторы фосфоинозидит-3-киназы и способы применения
HRP20200781T1 (hr) DERIVATI PIRAZOLO[1,5-a]PIRAZIN-4-ILA KAO INHIBITORI JAK
JP2018501315A5 (cg-RX-API-DMAC10.html)
JP2020536116A5 (cg-RX-API-DMAC10.html)
MX2008013400A (es) Derivado de azolcarboxamida.
IL274550B2 (en) Dopamine-b-hydroxylase inhibitors
JP2017531039A5 (cg-RX-API-DMAC10.html)
JP2013519724A5 (cg-RX-API-DMAC10.html)
AU2012342891B2 (en) 3-Cyanoaryl-1H-pyrrolo[2.3-b]pyridine derivatives
RU2015137103A (ru) Фуропиридины в качестве ингибиторов бромодоменов
HRP20121069T1 (hr) Supstituirani derivati amida kao inhibitori protein kinaze
RU2012126083A (ru) Производные аминооксазина
CN101605540A (zh) 使用mek抑制剂的方法
RU2017118165A (ru) Ингибиторы энхансера гомолога 2 zestes
JP2009515814A5 (cg-RX-API-DMAC10.html)
JP2016503785A5 (cg-RX-API-DMAC10.html)